2 results
Approved WMOCompleted
The primary objective of this study is to assess the overall safety and tolerability of subcutaneous (SC) trastuzumab using SID (Singel Injection Device) in HER2-positive eBC (early Breast Cancer) patients self-administered at home under supervision…
Approved WMOCompleted
Primary Objective: to explore whether UVB exposure leads to detectable changes of the biomarkers of the skin barrier, immune response and DNA-damage in urine and stratum corneum Secondary Objective(s): to explore the profile of biomarkers in…